Tocilizumab-induced erythroderma

被引：18
作者：
Nakamura, Motonobu [1 ]
Tokura, Yoshiki [1 ]
机构：
[1] Univ Occupat & Environm Hlth, Dept Dermatol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan
来源：
EUROPEAN JOURNAL OF DERMATOLOGY | 2009年 / 19卷 / 03期
关键词：
INTERLEUKIN-6; ANTIBODY;
D O I：
10.1684/ejd.2009.0642
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：273 / 274
页数：3
相关论文
共 5 条
[1]  
NISHIMOTO N, 2008, ANN RHEUM D IN PRESS
[2]   Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease [J].
Nishimoto, Norihiro ;
Terao, Kimio ;
Mima, Toru ;
Nakahara, Hideko ;
Takagi, Nobuhiro ;
Kakehi, Takahiro .
BLOOD, 2008, 112 (10) :3959-3964
[3]  
SATO K, 1993, CANCER RES, V53, P851
[4]  
SUGIURA F, 2008, MOD RHEUMAT IN PRESS
[5]   INTERLEUKIN-6 - INSIGHTS TO ITS FUNCTION IN SKIN BY OVEREXPRESSION IN TRANSGENIC MICE [J].
TURKSEN, K ;
KUPPER, T ;
DEGENSTEIN, L ;
WILLIAMS, I ;
FUCHS, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (11) :5068-5072
1